BCN is the official Publication of Neuroscience Departments of Tehran University of Medical Sciences and Shahid Beheshti University of Medical Sciences. BCN is an international multidisciplinary journal that publishes editorials, original full‐length research articles, short communications, reviews, methodological papers, commentaries, perspectives and “news and reports” in the broad fields of developmental, molecular, cellular, systems, computational, behavioral, cognitive, and clinical neurosciences. Manuscripts submitted to BCN should describe novel results generated by experiments that were guided by clearly defined aims or hypotheses and should not have appeared or submitted to any other journals. BCN’s aim is to provide serious ties in interdisciplinary communication, accessibility to a broad readership internationally, effective peer review process, and independence from all possible non scientific interests. BCN also tries to empower national, regional and international collaborative networks in the field of neuroscience and to be the voice of the Iranian and regional neuroscience community in the world of neuroscientists. BCN is a new journal dedicated to neuroscience field which intends to become an indexed and cited peer reviewed journal and to meet its quality standards in near future. To achieve this aim, BCN asks for support from all Iranian Neuroscientists doing research around the word in submitting manuscripts in all aspects of neuroscience research. We need your comments and valuable inputs. We are also asking Iranian Neuroscientists who are principle investigators to nominate as reviewers and/or editors in the different areas of neuroscience in BCN.
1 January 2017 in Research in Pharmaceutical Sciences
Oxidative stress and mitochondrial dysfunction are the main suggested mechanisms for neurodegenerative diseases. In this study, we have evaluated the effects of epicatechin (EC) on mitochondrial damage induced by homocycteine (Hcy) using isolated rat hippocampus mitochondria in vivo. EC (50 mg/kg) was gavaged daily for a period of 10 days, starting 5 days prior to Hcy (0.5 μmol/μL) intra hippocampus injection in rats. Mitochondria were isolated from brain by different centrifuge techniques. Mitochondrial function was assayed by MTT test. Also, mitochondrial swelling and oxidative stress markers, such as reactive oxygen species (ROS), lipid peroxidation and glutathione (GSH), were assayed. Hcy induced mitochondrial dysfunction and swelling. Increase in ROS formation, lipid peroxidation, and decreased GSH were observed after Hcy treatment in isolated brain mitochondria. Furthermore, oral administration of EC significantly decreased the lipid peroxidation and ROS levels and also increased GSH levels. Also, EC treatment significantly improved mitochondrial function. As EC indicated protective effects against oxidative stress and mitochondrial damage induced by Hcy, it is suggested for further trials for prevention or treatments of neurodegenerative disorders such as Alzheimer disease.
Background: The serum glucose lowering, normalization animal body weight, and antioxidative stress effects of Mespilus germanica L. leaf extract were investigated in normal and streptozotocin-induced Balb/C mice. Methods: The phenol and flavonoid of the leaves of M. germanica were extracted by percolation and concentrated using a rotary evaporator. Its total phenol and flavonoid content was determined using folin and aluminum chloride methods, respectively. The study was conducted on 48 matured male Balb/C mice (20–30 g) divided into 6 groups (n = 8). Diabetes mellitus was induced by single intraperitoneal injection of 35 mg/kg of streptozotocin (STZ). Extracts of Mespilus germanica were used orally at the dose of 50, 100, and 200 mg/kg body weight per day for 21 days. Results: Oral administrations of the M. germanica L. leaf extract significantly decreased serum glucose, oxidative stress, and lipid peroxidation and maintained animal body weight during treatment period (p < 0.05) compared to metformin (200 mg/kg) in over 100 mg/kg, 200 mg/kg, and 50 mg/kg dosages, respectively. Conclusions: The present study indicated that the Mespilus germanica leaf extract significantly decreased serum glucose and maintained normal body weight in Balb/C diabetic mice.
4 August 2022 in Journal of Diabetes & Metabolic Disorders